These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 23880186)

  • 21. miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat.
    Merlet E; Atassi F; Motiani RK; Mougenot N; Jacquet A; Nadaud S; Capiod T; Trebak M; Lompré AM; Marchand A
    Cardiovasc Res; 2013 Jun; 98(3):458-68. PubMed ID: 23447642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia.
    Tan J; Yang L; Liu C; Yan Z
    Sci Rep; 2017 Apr; 7():46602. PubMed ID: 28429763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cinaciguat prevents neointima formation after arterial injury by decreasing vascular smooth muscle cell migration and proliferation.
    Hirschberg K; Tarcea V; Páli S; Barnucz E; Gwanmesia PN; Korkmaz S; Radovits T; Loganathan S; Merkely B; Karck M; Szabó G
    Int J Cardiol; 2013 Jul; 167(2):470-7. PubMed ID: 22357420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model.
    Guan S; Tang Q; Liu W; Zhu R; Li B
    Drug Dev Res; 2014 Dec; 75(8):489-96. PubMed ID: 25452110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mir-22-3p Inhibits Arterial Smooth Muscle Cell Proliferation and Migration and Neointimal Hyperplasia by Targeting HMGB1 in Arteriosclerosis Obliterans.
    Huang SC; Wang M; Wu WB; Wang R; Cui J; Li W; Li ZL; Li W; Wang SM
    Cell Physiol Biochem; 2017; 42(6):2492-2506. PubMed ID: 28848136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CKLF1 aggravates neointimal hyperplasia by inhibiting apoptosis of vascular smooth muscle cells through PI3K/AKT/NF-κB signaling.
    Duan Y; Zhang Y; Qu C; Yu W; Tana ; Shen C
    Biomed Pharmacother; 2019 Sep; 117():108986. PubMed ID: 31387172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B cell translocation gene, a direct target of miR-142-5p, inhibits vascular smooth muscle cell proliferation by down-regulating cell cycle progression.
    Kee HJ; Park S; Kwon JS; Choe N; Ahn Y; Kook H; Jeong MH
    FEBS Lett; 2013 Aug; 587(15):2385-92. PubMed ID: 23770100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
    Cheng Y; Liu X; Yang J; Lin Y; Xu DZ; Lu Q; Deitch EA; Huo Y; Delphin ES; Zhang C
    Circ Res; 2009 Jul; 105(2):158-66. PubMed ID: 19542014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BubR1 insufficiency inhibits neointimal hyperplasia through impaired vascular smooth muscle cell proliferation in mice.
    Kyuragi R; Matsumoto T; Harada Y; Saito S; Onimaru M; Nakatsu Y; Tsuzuki T; Nomura M; Yonemitsu Y; Maehara Y
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):341-7. PubMed ID: 25524773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype.
    van der Veer EP; de Bruin RG; Kraaijeveld AO; de Vries MR; Bot I; Pera T; Segers FM; Trompet S; van Gils JM; Roeten MK; Beckers CM; van Santbrink PJ; Janssen A; van Solingen C; Swildens J; de Boer HC; Peters EA; Bijkerk R; Rousch M; Doop M; Kuiper J; Schalij MJ; van der Wal AC; Richard S; van Berkel TJ; Pickering JG; Hiemstra PS; Goumans MJ; Rabelink TJ; de Vries AA; Quax PH; Jukema JW; Biessen EA; van Zonneveld AJ
    Circ Res; 2013 Oct; 113(9):1065-75. PubMed ID: 23963726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia.
    Liu X; Cheng Y; Zhang S; Lin Y; Yang J; Zhang C
    Circ Res; 2009 Feb; 104(4):476-87. PubMed ID: 19150885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Pathological Role of hnRNPA1 (Heterogeneous Nuclear Ribonucleoprotein A1) in Vascular Smooth Muscle Cell Function and Neointima Hyperplasia.
    Zhang L; Chen Q; An W; Yang F; Maguire EM; Chen D; Zhang C; Wen G; Yang M; Dai B; Luong LA; Zhu J; Xu Q; Xiao Q
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2182-2194. PubMed ID: 28912364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrogen-rich saline attenuates vascular smooth muscle cell proliferation and neointimal hyperplasia by inhibiting reactive oxygen species production and inactivating the Ras-ERK1/2-MEK1/2 and Akt pathways.
    Chen Y; Jiang J; Miao H; Chen X; Sun X; Li Y
    Int J Mol Med; 2013 Mar; 31(3):597-606. PubMed ID: 23340693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-21 inhibits c-Ski signaling to promote the proliferation of rat vascular smooth muscle cells.
    Li J; Zhao L; He X; Yang T; Yang K
    Cell Signal; 2014 Apr; 26(4):724-9. PubMed ID: 24388835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of interleukin-1 receptor-associated kinase-1 in vascular smooth muscle cell proliferation and neointimal formation after rat carotid injury.
    Jain M; Singh A; Singh V; Barthwal MK
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1445-55. PubMed ID: 25908764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of mir-542-3p promotes neointimal formation in the aging rat.
    Qian DH; Gao P; Feng H; Qin ZX; Li JB; Huang L
    Vascul Pharmacol; 2015 Sep; 72():118-29. PubMed ID: 26026397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-125b Affects Vascular Smooth Muscle Cell Function by Targeting Serum Response Factor.
    Chen Z; Wang M; Huang K; He Q; Li H; Chang G
    Cell Physiol Biochem; 2018; 46(4):1566-1580. PubMed ID: 29689557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats.
    Buglak NE; Jiang W; Bahnson ESM
    Redox Biol; 2018 Oct; 19():166-178. PubMed ID: 30172101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice.
    Krohn R; Raffetseder U; Bot I; Zernecke A; Shagdarsuren E; Liehn EA; van Santbrink PJ; Nelson PJ; Biessen EA; Mertens PR; Weber C
    Circulation; 2007 Oct; 116(16):1812-20. PubMed ID: 17893273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RING finger protein 10 prevents neointimal hyperplasia by promoting apoptosis in vitro and in vivo.
    Yu G; Chen J; Li S; Pu P; Huang W; Zhao Y; Peng X; Wang R; Lei H
    Life Sci; 2018 Sep; 208():325-332. PubMed ID: 29723537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.